The World’s First Sphingosine Phosphate Lyase Insufficiency Syndrome (SPLIS) or NPHS14 Patient Registry Powered by Jeeva™

The World’s First Sphingosine Phosphate Lyase Insufficiency Syndrome (SPLIS) or NPHS14 Patient Registry Powered by Jeeva™

The pediatric oncology study team led by Julie Saba, MD, Ph.D., operates at UCSF medical center in San Francisco, CA, US, where they are building a patient registry for Sphingosine Phosphate Lyase Insufficiency Syndrome, also known as, SGPL1 Deficiency, Steroid Resistant Nephrotic Syndrome Type 14 (NPHS14).

Posted in .